<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03669510</url>
  </required_header>
  <id_info>
    <org_study_id>14422016552019</org_study_id>
    <nct_id>NCT03669510</nct_id>
  </id_info>
  <brief_title>Assessment of the Neurosensory Alteration After Inferior Alveolar Nerve Lateralization</brief_title>
  <official_title>Assessment of the Neurosensory Alteration With Computer Guided Inferior Alveolar Nerve Lateralization Versus Non Guided Classic Technique</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mohamed Reda Mohamed Abdelhady</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      : Assessment of the neurosensory alteration with computer guided inferior alveolar nerve
      lateralization versus non guided classic technique and measuring stability of implant after
      placement
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 1, 2019</start_date>
  <completion_date type="Anticipated">December 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>atrophic posterior mandible requiring nerve lateralization</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assessment of the neurosensory alteration- sensation over time subjective(a scale 1-10)</measure>
    <time_frame>2 months up to 1 year</time_frame>
    <description>assessing the sensation regaining over time subjective (a scale 1-10 )</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Implant stability</measure>
    <time_frame>At the placement and after exposure ( up to 6 months )</time_frame>
    <description>Measurements of the implant stability immediately after placement by osstell</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">2</enrollment>
  <condition>Implant Site Reaction</condition>
  <arm_group>
    <arm_group_label>computer gaiuded IAN</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Computer guided surgical technique</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Classical technique</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Non computer guided surgical technique</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>computer guided IAN lateralization surgical technique</intervention_name>
    <description>Tthe neurosensory alterations with computer guided inferior alveolar nerve lateralization versus non guided classic technique</description>
    <arm_group_label>Classical technique</arm_group_label>
    <arm_group_label>computer gaiuded IAN</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients with with atrophied posterior mandibular ridge

          -  both sexes

          -  NO intra oral soft and hard tissue pathology

          -  NO systematic that contraindicate implant placement

        Exclusion Criteria:

          -  Presence pathological lesion

          -  Heavy smokers more than 20 cigarettes per day.

          -  patients with systemic disease that may affect normal healing
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>September 11, 2018</study_first_submitted>
  <study_first_submitted_qc>September 12, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 13, 2018</study_first_posted>
  <last_update_submitted>September 12, 2018</last_update_submitted>
  <last_update_submitted_qc>September 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">September 13, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Mohamed Reda Mohamed Abdelhady</investigator_full_name>
    <investigator_title>director</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

